On ECHEMI
Home > Drugs > Multiple cerebral infarction mental disorder
Multiple cerebral infarction mental disorder
Multiple infarct mental disorders are caused by cerebral arteriosclerosis affecting the blood supply to the brain, especially recurrent cerebrovascular accidents. Microemboli or ischemia of sclerotic plaques in the external cerebral arteries (carotid arteries or conical basilar arteries) cause scattered small infarcts in the center of the cerebral white matter, so it is called multiple infarct dementia. Multiple infarct mental disorders often develop in middle-aged and elderly people. The degree of cerebral arteriosclerosis may vary depending on the location. The middle cerebral artery and the basilar artery are more susceptible to sclerosis. Multiple infarct mental disorders have thickening of the walls of the precapillary arteries, and more fractures of the elastic layer. Changes such as capillary hyalinization and fibrosis can also be seen in the basal ganglia. The brain has diffuse and localized atrophy, and the ventricles are enlarged. Microscopic examination shows that there are small softening foci of infarction of varying sizes in the frontal lobe and the center of the white matter. There is glial cell proliferation around the softening foci, forming small capsules or scars and epilepsy sparse areas. Neuronal degeneration and glial cell proliferation are most obvious around blood vessels. Arteriosclerosis can also be seen in organs such as the heart and kidneys, among which retinal arteriosclerosis is the most common.
  • Site of disease:

    Brain
  • Infectious :

    Not contagious
  • Frequent population:

    Mostly starts in middle-aged and elderly people
  • Related symptoms:

    Atherosclerosis Bonson infarction Confusion Sclerosis Memory impairment
  • Concurrent disease:

Related Drugs
Edaravone Injection
Indication: Acute cerebral infarction neuroprotective agent, mainly used to treat neurological damage caused by acute cerebral infarction, improve neurological symptoms and daily life movement disorders.
Manufacturer:

Simcere Pharmaceutical Co., Ltd.

Cerebroprotein Hydrolysate Injection
Indication: Used to improve symptoms of craniocerebral trauma, sequelae of cerebrovascular disease accompanied by memory loss and attention disorder.
Ginseng Rejuvenating Pills
Manufacturer:

Tong Ren Tang Technologies Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.